Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mayumi Ono

Showing results (61-70 of 129) with videos related to

Pageof 13
Sort By:
International Journal of Cancer|May 27, 2003
Downregulation of Cap43 gene by von Hippel-Lindau tumor suppressor protein in human renal cancer cellsKatsuaki Masuda, Mayumi Ono, Masahiro Okamoto, et al.
Molecular Cancer Therapeutics|August 19, 2007
Alteration of dihydropyrimidine dehydrogenase expression by IFN-alpha affects the antiproliferative effects of 5-fluorouracil in human hepatocellular carcinoma cellsShinji Oie, Mayumi Ono, Hiroto Fukushima, et al.
The Journal of Biological Chemistry|July 13, 2013
N-myc downstream-regulated gene 1 promotes tumor inflammatory angiogenesis through JNK activation and autocrine loop of interleukin-1α by human gastric cancer cellsYuichi Murakami, Kosuke Watari, Tomohiro Shibata, et al.
Human Pathology|October 6, 2009
N-myc downstream regulated gene-1/Cap43 may play an important role in malignant progression of prostate cancer, in its close association with E-cadherinYooHyun Song, Yoshinao Oda, Mikifumi Hori, et al.
Cancer Science|January 31, 2013
Sorting nexin 2-mediated membrane trafficking of c-Met contributes to sensitivity of molecular-targeted drugsSayaka Ogi, Hideaki Fujita, Masaki Kashihara, et al.
Cancer Research|November 15, 2019
Bidirectional Regulation between NDRG1 and GSK3β Controls Tumor Growth and Is Targeted by Differentiation Inducing Factor-1 in GlioblastomaHiroshi Ito, Kosuke Watari, Tomohiro Shibata, et al.
Molecular Cancer Therapeutics|December 20, 2002
Antiangiogenic effect by SU5416 is partly attributable to inhibition of Flt-1 receptor signalingTakashi Itokawa, Hiroki Nokihara, Yasuhiko Nishioka, et al.
Oncotarget|August 14, 2014
FGFR1 activation is an escape mechanism in human lung cancer cells resistant to afatinib, a pan-EGFR family kinase inhibitorKoichi Azuma, Akihiko Kawahara, Kahori Sonoda, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|April 16, 2022
Comparative study of rapid antigen testing and two nucleic acid amplification tests for influenza virus detectionYuki Sato, Shinya Nirasawa, Masachika Saeki, et al.
Scientific Reports|January 19, 2016
Impaired differentiation of macrophage lineage cells attenuates bone remodeling and inflammatory angiogenesis in Ndrg1 deficient miceKosuke Watari, Tomohiro Shibata, Hiroshi Nabeshima, et al.
Pageof 13

Showing results (61-70 of 129) with videos related to

Sort By:
Pageof 13
International Journal of Cancer|May 27, 2003
Downregulation of Cap43 gene by von Hippel-Lindau tumor suppressor protein in human renal cancer cellsKatsuaki Masuda, Mayumi Ono, Masahiro Okamoto, et al.
Molecular Cancer Therapeutics|August 19, 2007
Alteration of dihydropyrimidine dehydrogenase expression by IFN-alpha affects the antiproliferative effects of 5-fluorouracil in human hepatocellular carcinoma cellsShinji Oie, Mayumi Ono, Hiroto Fukushima, et al.
The Journal of Biological Chemistry|July 13, 2013
N-myc downstream-regulated gene 1 promotes tumor inflammatory angiogenesis through JNK activation and autocrine loop of interleukin-1α by human gastric cancer cellsYuichi Murakami, Kosuke Watari, Tomohiro Shibata, et al.
Human Pathology|October 6, 2009
N-myc downstream regulated gene-1/Cap43 may play an important role in malignant progression of prostate cancer, in its close association with E-cadherinYooHyun Song, Yoshinao Oda, Mikifumi Hori, et al.
Cancer Science|January 31, 2013
Sorting nexin 2-mediated membrane trafficking of c-Met contributes to sensitivity of molecular-targeted drugsSayaka Ogi, Hideaki Fujita, Masaki Kashihara, et al.
Cancer Research|November 15, 2019
Bidirectional Regulation between NDRG1 and GSK3β Controls Tumor Growth and Is Targeted by Differentiation Inducing Factor-1 in GlioblastomaHiroshi Ito, Kosuke Watari, Tomohiro Shibata, et al.
Molecular Cancer Therapeutics|December 20, 2002
Antiangiogenic effect by SU5416 is partly attributable to inhibition of Flt-1 receptor signalingTakashi Itokawa, Hiroki Nokihara, Yasuhiko Nishioka, et al.
Oncotarget|August 14, 2014
FGFR1 activation is an escape mechanism in human lung cancer cells resistant to afatinib, a pan-EGFR family kinase inhibitorKoichi Azuma, Akihiko Kawahara, Kahori Sonoda, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|April 16, 2022
Comparative study of rapid antigen testing and two nucleic acid amplification tests for influenza virus detectionYuki Sato, Shinya Nirasawa, Masachika Saeki, et al.
Scientific Reports|January 19, 2016
Impaired differentiation of macrophage lineage cells attenuates bone remodeling and inflammatory angiogenesis in Ndrg1 deficient miceKosuke Watari, Tomohiro Shibata, Hiroshi Nabeshima, et al.
Pageof 13